The Effect of Nasogastric Tube Placement on Complications in Patients With Small Bowel Obstruction - the SBO-TUBE Trial

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity Hospital, Linkoeping

About this trial

Background: Small bowel obstruction (SBO) is a surgical emergency where the normal continuous bowel movements are hindered and approximately 8000-9000 patients visit the emergency department every year in Sweden due to SBO. A minority of these have evidence of intestinal injury, warranting emergency surgery, while the majority (70-90%) will have an initial plan for non-operative management with a nasogastric tube (NGT), placed to alleviate gastric pressure, reduce pain and prevent complications like aspiration pneumonia. The effectiveness of NGT in patients with SBO to prevent complications is unclear, with current data from observational data indicating increased risk of pneumonia in patients treated with NGT. Objective: To assess whether deferring the placement of a NGT in subjects with small bowel obstruction and planned for non-operative management leads to lower rates of respiratory complication compared to placing an NGT. Methods: This will be a randomized, controlled, open-label, multicenter study of patients with SBO and an initial plan for non-operative management. Patients will be randomized in a 1:1 ratio to not receive an NGT (intervention) or receive an NGT (control) and monitored regularly until the SBO resolves spontaneously or through surgery, whichever comes first. The primary outcome will be a composite of pulmonary complications and treatment in a high dependency unit, analyzed as a superiority study with an intention-to-treat framework with secondary per-protocol and non-inferiority analysis. The trial will recruit 1000 patients. Secondary analysis includes health-economy, qualitative interviews, and long term (1 year) follow up. Discussion: The current management of NGT in SBO is based on clinical and guideline-based recommendations with limited supporting data. Available data, albeit observational with risk for selection bias, indicates increased risk of complications. This equipoise warrants further investigation to understand the true benefit of NGT in SBO. This study will provide high quality evidence of the ability of a NGT to prevent complications in SBO through its randomized, prospective design

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Small bowel obstruction diagnosed on Computer Tomography

Disqualifiers

Nasogastric Tube already places

Amyotrophic lateral sclerosis

Cerebral palsy

Dementia

Trial design

Design model

Parallel

Treatments tested in this trial

  • Nasogastric tube placement

    Procedure/Surgery

    The placement of a nasogastric tube from the nares to gastric ventricle.

Treatment groups

1,000 Participants
are divided into 2 treatment groups
Group A: Nasogastric TubeExperimental treatment 1 intervention
Group B: No Nasogastric TubeNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Composite of Pulmonary complications and care at a high dependency unit or intensive care unit

Pulmonary complications, any of: * Respiratory infection - treatment with antibiotics supported by suggestive findings on x-ray and/or laboratory findings * Respiratory failure - new pulse-oximetry values below 90% or an increased need for supplemental oxygen for an oxygen saturation above 90%, measured by pulse-oximetry or blood gases. * Pleural effusion - based on x-ray findings * Atelectasis - based on x-ray findings * Pneumothorax - based on x-ray findings * Bronchospasm - documented wheezing or increased effort breathing * Aspiration pneumonitis - treatment with antibiotics supported by suggestive findings on x-ray and/or laboratory findings and a clinical correlation to an event of vomiting/dysphagia High dependency unit or Intensive care unit This study will use the definitions of pulmonary complications defined by Jammer et al: Individual components of the composite endpoint will be reported and analysed separately as secondary endpoints.

Time frame
From enrollment until 30 days or hospital discharge

Secondary outcomes

1

Surgery

Requiring surgery for their small bowel obstruction

Time frame
From enrollment until 30 days or hospital discharge, whichever comes first
2

Death

Death from any cause

Time frame
From enrollment until 365 days
3

Time to functional recovery

Time to functional recovery is seen as a more objective outcome compared to hospital length of stay, which may be influenced by other factors, not related to the disease. Functional recovery is a composite of the following components: * Independently mobile at preoperative level * Sufficient pain control with oral medications only * Ability to maintain necessary caloric intake with parenteral nutrition of fluids * No intravenous fluid administration * No clinical signs of infection

Time frame
From enrollment until 30 days or hospital discharge, whichever comes first
4

Bowel perforation

As a finding, or complication, during surgery

Time frame
From enrollment until 30 days or hospital discharge, whichever comes first

Other outcomes

1

Recurrent Small Bowel Obstruction

Admission for small bowel obstruction

Time frame
From inclusion until 365 days
2

Health-related quality of life

Measured by the EQ-5D-5L tool

Time frame
Up to 30 days after hospital discharge
3

Number of required morphine-equivalents

Time frame
From inclusion until 30 days or hospital discharge, whichever comes first
4

Nausea

Nausea, measured on a numeric rating scale from 0 to 10

Time frame
From enrollment until 30 days or hospital admission, whichever comes first

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University Hospital, Linkoeping

Lead sponsor

Linkoeping University

Collaborator

Region Jönköping County

Collaborator